IR Biosciences Holdings Inc.’s (IRBS.OB)

IR Biosciences Holdings Inc.’s (IRBS.OB) subsidiary is a development-stage biotechnology company devoted to researching, developing and licensing Homspera® and its derivatives. Homspera is an adult stem cell active compound that has been demonstrated the ability to regenerate and strengthen the immune system as well as enhance wound healing. To further its mission, IR BioSciences has forged a number of study partnerships with industry and academic leaders. For more information, please visit www.immuneregen.com.